4//SEC Filing
Kuyper Dirk 4
Accession 0001127602-19-026120
CIK 0000816956other
Filed
Aug 5, 8:00 PM ET
Accepted
Aug 6, 11:42 AM ET
Size
24.2 KB
Accession
0001127602-19-026120
Insider Transaction Report
Form 4
CONMED CORPCNMD
Kuyper Dirk
Director
Transactions
- Exercise/Conversion
Common Stock
2019-08-02$41.06/sh+5,396$221,560→ 10,396 total - Sale
Common Stock
2019-08-02$91.10/sh−5,396$491,576→ 5,000 total - Exercise/Conversion
Common Stock
2019-08-02$69.03/sh+2,549$175,957→ 7,549 total - Sale
Common Stock
2019-08-02$91.17/sh−2,549$232,392→ 5,000 total - Disposition to Issuer
Options To Purchase Common Stock
2019-08-01−2,165→ 0 totalExercise: $79.94From: 2020-06-01Exp: 2029-06-03→ Common Stock (2,165 underlying) - Disposition to Issuer
Rsus (restricted Stock Units)
2019-08-01−1,407→ 0 totalExercise: $0.00From: 2020-06-01Exp: 2029-06-03→ Common Stock (1,407 underlying) - Sale
Common Stock
2019-08-02$91.04/sh−3,669$334,026→ 5,000 total - Exercise/Conversion
Common Stock
2019-08-02$51.90/sh+3,669$190,421→ 8,669 total - Exercise/Conversion
Options To Purchase Common Stock
2019-08-02−5,396→ 0 totalExercise: $41.06From: 2017-06-01Exp: 2026-06-01→ Common Stock (5,396 underlying) - Exercise/Conversion
Options To Purchase Common Stock
2019-08-02−3,669→ 0 totalExercise: $51.90From: 2018-06-01Exp: 2027-06-01→ Common Stock (3,669 underlying) - Exercise/Conversion
Options To Purchase Common Stock
2019-08-02−2,549→ 0 totalExercise: $69.03From: 2019-06-01Exp: 2028-06-01→ Common Stock (2,549 underlying)
Footnotes (7)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $91.00 to $91.68. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $91.00 to $91.19. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $91.00 to $91.33. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
- [F4]The stock options expired without vesting as a consequence of Mr. Kuyper's resignation from the Board prior to the completion of the 2019 term of service.
- [F5]The incentive stock options ("ISOs") were granted under the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period.
- [F6]The RSUs expired without vesting as a consequence of Mr. Kuyper's resignation from the Board prior to the completion of the 2019 term of service.
- [F7]Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period.
Documents
Issuer
CONMED CORP
CIK 0000816956
Entity typeother
Related Parties
1- filerCIK 0001404850
Filing Metadata
- Form type
- 4
- Filed
- Aug 5, 8:00 PM ET
- Accepted
- Aug 6, 11:42 AM ET
- Size
- 24.2 KB